InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Verwiel Frank, Director. Officer active across 1 company, notably Intellia Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €35k. Activity tracked since 23 June 2021. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Verwiel Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,000 shares0Common StockSEC:0000950170-25-086287:0
1,505 shares@ US$25.00100.0% of flowCommon StockSEC:0000950170-24-075718:0
7,737 shares0Common StockSEC:0000950170-24-073704:0
4,425 shares0Common StockSEC:0001209191-23-037898:0
5,197 shares0Common StockSEC:0001209191-22-037604:0
2,094 shares0Common StockSEC:0001209191-21-043385:0
6 of 6 declarations
About Verwiel Frank
Frank Verwiel is a Board Member at Intellia Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
